Targeting the OXE receptor with a selective antagonist inhibits allergen‐induced pulmonary inflammation in non‐human primates is a research paper published in British Journal of Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: PP2‐133388
NIH HHS
Grant: P51 OD011107
National Heart, Lung, and Blood Institute
Grant: R01HL081873
American Asthma Foundation
Grant: 12‐0049
National Science Foundation
Grant: CHE‐03‐42251
CIHR
Grant: MOP-6254
Canadian Institutes of Health Research
Grant: MOP‐6254
National Science Foundation
Grant: CHE‐90‐13145
CIHR
Grant: PP2-133388
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL081873-14
Biochemical Pathways of 12-HETE and 12-KETE Metabolism
FWCI
0.84
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals